About ApiJect
ApiJect is a company based in Stamford (United States) founded in 2015 by Marc Koska and Jay Walker.. ApiJect has raised $111 million across 2 funding rounds from investors including Royalty Pharma, Jefferies and DFC. ApiJect offers products and services including Blow-Fill-Seal Container, Apiject Platform, and Prefilled Injector. ApiJect operates in a competitive market with competitors including Exela Pharma, August Bioservices, Gland Pharma, Vetter Pharma and INCOG BioPharma Services, among others.
- Headquarter Stamford, United States
- Founders Marc Koska, Jay Walker
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Apiject Systems, Corp.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$111 M (USD)
in 2 rounds
-
Latest Funding Round
$111 M (USD), Series D
Apr 15, 2022
-
Investors
Royalty Pharma
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ApiJect
ApiJect offers a comprehensive portfolio of products and services, including Blow-Fill-Seal Container, Apiject Platform, and Prefilled Injector. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Aseptic container for prefilled injections ensuring safety and sterility.
Platform simplifying injections for pharmaceuticals and global health use.
Device enabling easy administration by non-professionals in various settings.
Unlock access to complete
Funding Insights of ApiJect
ApiJect has successfully raised a total of $111M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $111 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series D — $111.0M
-
First Round
First Round
(19 Nov 2020)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Series D - ApiJect | Valuation | Royalty Pharma , Jefferies |
|
| Nov, 2020 | Amount | Debt – Conventional - ApiJect | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ApiJect
ApiJect has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Royalty Pharma, Jefferies and DFC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in marketed and late-stage biopharmaceutical companies.
|
Founded Year | Domain | Location | |
|
Government agency supporting the development of SMEs
|
Founded Year | Domain | Location | |
|
Merger and acquisitions advisory services are provided across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ApiJect
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ApiJect
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Apiject Comparisons
Competitors of ApiJect
ApiJect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, August Bioservices, Gland Pharma, Vetter Pharma and INCOG BioPharma Services, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| domain | founded_year | HQ Location |
Diversified research services for clinical solutions are offered.
|
|
| domain | founded_year | HQ Location |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| domain | founded_year | HQ Location |
CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.
|
|
| domain | founded_year | HQ Location |
Injectable drug products are manufactured by this biopharma CDMO.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Apiject
Frequently Asked Questions about ApiJect
When was ApiJect founded?
ApiJect was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Where is ApiJect located?
ApiJect is headquartered in Stamford, United States. It is registered at Stamford, Connecticut, United States.
Who is the current CEO of ApiJect?
Jay Walker is the current CEO of ApiJect. They have also founded this company.
Is ApiJect a funded company?
ApiJect is a funded company, having raised a total of $111M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $590M, raised on Nov 19, 2020.
What does ApiJect do?
ApiJect manufacturer of medicine injectors, focusing on providing healthcare solutions, biopharma outsourcing, cdmo, small molecules peptides, formulation, and injectibles. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of ApiJect?
ApiJect's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
What products or services does ApiJect offer?
ApiJect offers Blow-Fill-Seal Container, Apiject Platform, and Prefilled Injector.
Who are ApiJect's investors?
ApiJect has 3 investors. Key investors include Royalty Pharma, Jefferies, and DFC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.